Alembic Ltd.
| BSE: 506235 | Sector: Health care |
| NSE: ALEMBICLTD | ISIN Code: INE426A01027 |
| BSE 16:01 | 27 Jan | 68.50 |
-1.00 (-1.44%) |
OPEN
69.55 |
HIGH
69.90 |
LOW
68.00 |
| NSE 15:44 | 27 Jan | 68.60 |
-0.90 (-1.29%) |
OPEN
69.90 |
HIGH
69.90 |
LOW
68.00 |
| OPEN | 69.55 |
| PREVIOUS CLOSE | 69.50 |
| VOLUME | 11527 |
| 52-Week high | 102.85 |
| 52-Week low | 56.50 |
| P/E | 24.04 |
| Mkt Cap.(Rs cr) | 1,759 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Alembic Ltd. (ALEMBICLTD) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 1040.75 | 0.08 | 1070.80 | 785.00 | 249707.14 |
| Divi's Lab. | 3385.55 | 1.47 | 4640.95 | 3197.00 | 89869.43 |
| Cipla | 1051.80 | 1.68 | 1185.20 | 880.00 | 84896.03 |
| Dr Reddy's Labs | 4321.35 | 2.78 | 4645.55 | 3655.00 | 71959.12 |
| Apollo Hospitals | 4260.90 | 0.85 | 5015.45 | 3365.90 | 61263.22 |
| Torrent Pharma. | 1537.85 | -1.26 | 1722.70 | 1242.50 | 52047.00 |
| Abbott India | 21279.00 | 0.00 | 22481.80 | 15525.00 | 45217.88 |
| Max Healthcare | 455.15 | 3.94 | 482.50 | 306.00 | 44187.78 |
| Zydus Lifesci. | 433.35 | 1.70 | 458.60 | 319.40 | 43863.69 |
| Alkem Lab | 2997.60 | -0.54 | 3720.00 | 2835.00 | 35836.31 |
| Lupin | 743.00 | -0.44 | 930.15 | 583.05 | 33799.07 |
| Biocon | 235.50 | 0.08 | 410.50 | 232.65 | 28274.13 |
| Aurobindo Pharma | 416.25 | -0.38 | 730.00 | 409.20 | 24388.09 |
| Syngene Intl. | 565.00 | -1.22 | 682.25 | 508.10 | 22680.79 |
| Gland Pharma | 1359.00 | 1.30 | 3599.00 | 1309.00 | 22382.73 |
| Ipca Labs. | 848.15 | -1.83 | 1089.00 | 830.00 | 21517.57 |
| Glaxosmi. Pharma | 1264.95 | 0.16 | 1734.90 | 1256.15 | 21429.52 |
| Fortis Health. | 280.30 | 0.97 | 324.80 | 219.80 | 21161.53 |
| Laurus Labs | 342.80 | 0.23 | 626.00 | 337.25 | 18464.92 |
| Pfizer | 4004.20 | -0.26 | 4800.00 | 3983.40 | 18319.22 |
Quick Links for Alembic:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
